» Articles » PMID: 33783365

Comparing the Efficacies of Telemedicine and Standard Prenatal Care on Blood Glucose Control in Women With Gestational Diabetes Mellitus: Randomized Controlled Trial

Overview
Date 2021 Mar 30
PMID 33783365
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Gestational diabetes mellitus (GDM) can usually be well controlled by health education and lifestyle management, resulting in better pregnancy outcomes. However, standard clinical prenatal care, which consists of clinic visits every 2 weeks, may not provide sufficient management for women with GDM. Telemedicine demonstrates a potential to fill this gap.

Objective: The objective of this study was to investigate whether health education and lifestyle management delivered through a WeChat group chat was more effective in controlling blood glucose (BG) than standard clinical prenatal care among women with GDM.

Methods: In this multicenter randomized controlled trial, women with GDM diagnosed by an oral glucose tolerance test between 23 and 30 (+6) gestational weeks were randomized to a WeChat group chat-based BG management group or a routine clinical prenatal care group. The primary outcome was the change in the glycemic qualification rate during the follow-up period in both groups. The secondary outcomes were pregnancy outcomes.

Results: A total of 309 women with GDM participated in the trial, with 162 women randomized to the control group and 147 to the intervention group. No significant differences in baseline characteristics were found between the control and intervention groups. Participants were further divided into 4 groups according to gestational weeks at enrollment for further analysis. The glycemic qualification rate of the intervention group was higher than that of the control group at nearly all time points in Groups 1 to 3, among which 3 time points reached statistical significance: Group 1 at T3 (54.8% vs 83.3%) and Group 2 at T3 (62.5% vs 80.0%) and T7 (75.0% vs 100%). The glycemic qualification rate gradually increased as gestational weeks progressed in both groups, regardless of the intervention method. None of the pregnancy outcomes measured, including delivery mode, premature rupture of the membranes, preterm birth, infant's birth weight, and postpartum hemorrhage, were significantly different between the control and intervention groups.

Conclusions: This multicenter randomized controlled trial that assessed women with noninsulin-dependent GDM demonstrated that additional instant messaging platforms, such as WeChat, used for health education and lifestyle intervention in China tend to be more effective for BG control than standard clinical prenatal care alone.

Trial Registration: ClinicalTrials.gov NCT03748576; https://clinicaltrials.gov/ct2/show/NCT03748576.

Citing Articles

SPARK: an mHealth intervention for self-management and treatment of gestational diabetes mellitus in Sweden - protocol for a randomised controlled trial.

Lilliecreutz C, Soderstrom E, Ersson M, Bendtsen M, Brown V, Kaegi-Braun N BMJ Open. 2025; 15(3):e089355.

PMID: 40032379 PMC: 11877236. DOI: 10.1136/bmjopen-2024-089355.


Self-care interventions among women with gestational diabetes mellitus in low and middle-income countries: a scoping review.

Dang N, Le H, Nguyen A, Glode P, Vinter C, Nielsen J Syst Rev. 2025; 14(1):50.

PMID: 40016820 PMC: 11866587. DOI: 10.1186/s13643-025-02790-7.


Telemedicine and Gestational Diabetes Mellitus: Systematic Review and Meta-Analysis.

El Seifi O, Younis F, Ibrahim Y, Begum S, Ahmed S, Zayed E Cureus. 2024; 16(10):e71907.

PMID: 39564055 PMC: 11574696. DOI: 10.7759/cureus.71907.


Implementing telemedicine for the care of women with gestational diabetes mellitus in a rural hospital: an observational retrospective study.

Tancredi M, Chrusciel J, Zaouia S, Mergey V, Laplanche D, Sanchez S BMC Health Serv Res. 2024; 24(1):1316.

PMID: 39478623 PMC: 11526511. DOI: 10.1186/s12913-024-11726-1.


Nutritional guidance through digital media for glycemic control of women with gestational diabetes mellitus: a randomized clinical trial.

Valenca M, Franca M, Mattar R, Dualib P, Sanchez V, de Almeida-Pititto B J Perinat Med. 2024; 53(1):15-24.

PMID: 39425957 DOI: 10.1515/jpm-2024-0294.


References
1.
Metzger B, Lowe L, Dyer A, Trimble E, Chaovarindr U, Coustan D . Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008; 358(19):1991-2002. DOI: 10.1056/NEJMoa0707943. View

2.
Mackillop L, Hirst J, Bartlett K, Birks J, Clifton L, Farmer A . Comparing the Efficacy of a Mobile Phone-Based Blood Glucose Management System With Standard Clinic Care in Women With Gestational Diabetes: Randomized Controlled Trial. JMIR Mhealth Uhealth. 2018; 6(3):e71. PMC: 5883074. DOI: 10.2196/mhealth.9512. View

3.
Hirst J, Mackillop L, Loerup L, Kevat D, Bartlett K, Gibson O . Acceptability and user satisfaction of a smartphone-based, interactive blood glucose management system in women with gestational diabetes mellitus. J Diabetes Sci Technol. 2014; 9(1):111-5. PMC: 4495541. DOI: 10.1177/1932296814556506. View

4.
. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: a World Health Organization Guideline. Diabetes Res Clin Pract. 2014; 103(3):341-63. DOI: 10.1016/j.diabres.2013.10.012. View

5.
Martis R, Crowther C, Shepherd E, Alsweiler J, Downie M, Brown J . Treatments for women with gestational diabetes mellitus: an overview of Cochrane systematic reviews. Cochrane Database Syst Rev. 2018; 8:CD012327. PMC: 6513179. DOI: 10.1002/14651858.CD012327.pub2. View